Biotech Blueprint

FDA Shifts to One Pivotal Trial and Moderna Flu Shot Back Under FDA Review – This Week in Biotech #90

Hims Launches Compounded GLP-1 Pill, CVS Forces Biosimilars – This Week in Biotech #88

Regenxbio FDA Hold, Sanofi Vaccine Demand Softness, and CMS Negotiation Expansion – This Week in Biotech #87

Moderna Merck V940 Shows Five Year Melanoma Durability, Biopharma Deal Activity Picks Up

#CDC #Vaccine Schedule Shifts, Practice-Changing Phase 3 Wins, and Deal Heat – This Week in Biotech #84